Algert Global LLC Purchases Shares of 3,279 Agilent Technologies, Inc. (NYSE:A)

Algert Global LLC purchased a new stake in Agilent Technologies, Inc. (NYSE:A) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 3,279 shares of the medical research company’s stock, valued at approximately $487,000.

A number of other hedge funds also recently modified their holdings of A. Atria Investments Inc lifted its holdings in shares of Agilent Technologies by 26.6% during the 1st quarter. Atria Investments Inc now owns 11,841 shares of the medical research company’s stock worth $1,723,000 after acquiring an additional 2,491 shares during the period. Cetera Investment Advisers boosted its holdings in Agilent Technologies by 953.3% during the first quarter. Cetera Investment Advisers now owns 32,694 shares of the medical research company’s stock valued at $4,757,000 after purchasing an additional 29,590 shares in the last quarter. Cetera Advisors LLC grew its stake in shares of Agilent Technologies by 45.7% in the 1st quarter. Cetera Advisors LLC now owns 13,620 shares of the medical research company’s stock valued at $1,982,000 after purchasing an additional 4,274 shares during the period. EverSource Wealth Advisors LLC raised its holdings in shares of Agilent Technologies by 36.4% in the 1st quarter. EverSource Wealth Advisors LLC now owns 731 shares of the medical research company’s stock worth $100,000 after buying an additional 195 shares in the last quarter. Finally, GAMMA Investing LLC lifted its position in shares of Agilent Technologies by 54.0% during the 2nd quarter. GAMMA Investing LLC now owns 1,583 shares of the medical research company’s stock worth $205,000 after buying an additional 555 shares during the period.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on A shares. UBS Group increased their price objective on Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Wells Fargo & Company assumed coverage on shares of Agilent Technologies in a research report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 target price for the company. Sanford C. Bernstein reduced their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research report on Tuesday, November 26th. TD Cowen raised their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Finally, Evercore ISI boosted their target price on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, Agilent Technologies has an average rating of “Hold” and a consensus target price of $143.40.

Agilent Technologies Trading Down 0.1 %

A opened at $137.97 on Friday. The firm has a 50 day simple moving average of $137.60 and a 200 day simple moving average of $137.27. Agilent Technologies, Inc. has a fifty-two week low of $124.16 and a fifty-two week high of $155.35. The company has a market cap of $39.64 billion, a price-to-earnings ratio of 31.21, a price-to-earnings-growth ratio of 4.38 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.37.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.248 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date is Tuesday, December 31st. This represents a $0.99 annualized dividend and a dividend yield of 0.72%. Agilent Technologies’s payout ratio is presently 21.27%.

Insider Activity

In other news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. This represents a 19.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.